ECLIA: Anti-SARS-CoV-2 antibodies were examined using the ECLIA method on the Cobas e411 autoanalyzer, Roche. The sample results were stated as reactive or nonreactive in the form of a cut-off index (COI). Meanwhile, Anti-S-RBD SARS-CoV-2-S antibody examination was carried out using the ECLIA method on the Cobas e411 autoanalyzer, Roche. The test results were declared negative when < 0.80 U/mL and positive when the value was 0.80 U/mL. Data Analysis: Data were collected at 7 and 26 weeks after the participants had received the second dose of vaccine. About 34 out of 194 participants were excluded due to active infection during sample collection. Up to the 26th week of follow-up, participants who
Cobas e411 autoanalyzer
The Cobas e411 autoanalyzer is a compact, automated immunoassay analyzer designed for clinical laboratories. It is capable of performing a variety of immunoassay tests, including those for hormones, therapeutic drug monitoring, and infectious disease markers. The Cobas e411 autoanalyzer features automated sample handling, reagent management, and result calculation to provide efficient and reliable testing.
Lab products found in correlation
9 protocols using cobas e411 autoanalyzer
Antibody Response After COVID-19 Vaccination
ECLIA: Anti-SARS-CoV-2 antibodies were examined using the ECLIA method on the Cobas e411 autoanalyzer, Roche. The sample results were stated as reactive or nonreactive in the form of a cut-off index (COI). Meanwhile, Anti-S-RBD SARS-CoV-2-S antibody examination was carried out using the ECLIA method on the Cobas e411 autoanalyzer, Roche. The test results were declared negative when < 0.80 U/mL and positive when the value was 0.80 U/mL. Data Analysis: Data were collected at 7 and 26 weeks after the participants had received the second dose of vaccine. About 34 out of 194 participants were excluded due to active infection during sample collection. Up to the 26th week of follow-up, participants who
Seroprevalence of SARS-CoV-2 IgG Antibodies
The seroprevalence was estimated based on the IgG isotype, since IgM does not provide long-term memory information [20 (link)]. In this sense, the detection of IgG makes it possible to evaluate the scope of herd immunity as a monitoring and epidemiological surveillance strategy. A blood sample was used from each participant with prior informed consent to determine the presence of anti-SARS-CoV-2 IgG antibodies by means of an electrochemiluminescence immunoassay, Elecsys® Anti-SARS-CoV-2, Precicontrol, using a COBAS e411 autoanalyzer (Roche Diagnostics). Anti-N IgG titers were considered positive with a cut-off index of >1.
Comprehensive Cardiometabolic Assessment
Fasting blood glucose and lipid profile was quantified using routine biochemical tests in an automated biochemistry analyzer (Konelab 20, Thermo-Fischer scientific, Helsinki, Finland). The reagents were supplied ready to use by Thermo Fischer (catalog# 981379 for glucose; 981812 for total cholesterol; 981823 for HDL-cholesterol and 981301 for triglyceride). The imprecision, calculated as the total CV, was ≤5%, ≤3.5%, ≤4% and ≤4% for these tests respectively. 25(OH)vitamin D was quantified using COBAS e-411 autoanalyzer (Roche Diagnostics, Indianapolis, IN, USA). Glycated haemoglobin (HbA1c) was quantified in DCA vantage analyzer (Siemens, Munich, Germany). The imprecision of the HbA1c assay was ≤3.6% in the important clinical ranges. The standards and controls used for these biochemical assays were routinely tested by Quality assurance department of KSU, for highly reproducible research data.
Hormonal Biomarker Assessment in Blood
Bone Biomarker Assessment in Serum
Vitamin D Levels in Transplant Patients
Adjusting Immune Marker-Metabolite Correlations for CMV
Evaluating Metabolic Markers in Fasting Patients
In addition, the Homeostatic Model Assessment for insulin resistance (HOMA-IR) and for insulin sensitivity (HOMA-IS) was calculated. 6, 10 Insulin resistance index ðHOMA À IRÞ ¼ ffasting insulin level ðmU=LÞ fasting plasma glucose ðmmol=LÞg=22:5 Insulin sensitivity index ðHOMA À ISÞ ¼ 1= È fasting insulin level ðmU=LÞ fasting plasma glucose ðmmol=LÞ
Biomarker Analysis in Fasting Whole Blood
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!